Walters Group is > 10% Shareholder of Zentalis Pharmaceuticals, Inc.. Currently has a direct ownership of 13.5 Million shares of ZNTL, which is worth approximately $18 Million. The most recent transaction as insider was on Dec 31, 2025, when has been sold 6,459,973 shares (Common Stock) at a price of $1.2 per share, resulting in proceeds of $7,751,967. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.5M
n/a 3M change
n/a 12M change
Total Value Held $18 Million

WALTERS GROUP Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 31 2025
BUY
Open market or private purchase
$7,751,967 $1.2 p/Share
6,459,973 Added 32.35%
13,509,973 Common Stock
WG

Walters Group

> 10% Shareholder
Henderson, NV

Track Institutional and Insider Activities on ZNTL

Follow Zentalis Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZNTL shares.

Notify only if

Insider Trading

Get notified when an Zentalis Pharmaceuticals, Inc. insider buys or sells ZNTL shares.

Notify only if

News

Receive news related to Zentalis Pharmaceuticals, Inc.

Track Activities on ZNTL